Synthesis and molecular modelling of thiadizole based hydrazone derivatives as acetylcholinesterase and butyrylcholinesterase inhibitory activities

dc.contributor.authorIsik, A.
dc.contributor.authorCevik, U. Acar
dc.contributor.authorKarayel, A.
dc.contributor.authorCelik, I
dc.contributor.authorErcetin, T.
dc.contributor.authorKocak, A.
dc.contributor.authorKaplancikli, Z. A.
dc.date.accessioned2026-02-06T18:46:59Z
dc.date.issued2022
dc.departmentDoğu Akdeniz Üniversitesi
dc.description.abstractSome novel substituted thiazolylhydrazine derivatives were designed, synthesized and their inhibitory effects on acetylcholinesterase (AChE) and butyrylcholinesterase (BuChE) enzymes and antioxidant activities were investigated. The structures of the synthesized compounds were determined using different spectroscopic techniques such as H-1-NMR, C-13-NMR, and HRMS. According to the enzyme inhibition results, the synthesized compounds showed selectivity against BuChE enzyme inhibition. Compounds 5e, 5g, 5i and 5j displayed significant BuChE inhibition potencies. Among them, compound 5i was found to be the most effective derivative with an IC50 value of 56.01 +/- 0.054 mu M. In addition, their antioxidant properties were evaluated in vitro through the 2,2-diphenyl-1-picrylhydrazyl (DPPH) assay. For compounds 5e, 5g, 5i and 5j in silico molecular docking and 100 ns molecular dynamics simulations studies against the BuChE enzyme were performed to determine possible protein-ligand interactions and stability. DFT-D3 study was performed to stabilize of compounds 5e, 5g, 5i and 5j both in gas and solvent medium and investigated their electronic properties. Of all geometries, that of DMSO is the lowest one.
dc.identifier.doi10.1080/1062936X.2022.2041723
dc.identifier.endpage214
dc.identifier.issn1062-936X
dc.identifier.issn1029-046X
dc.identifier.issue3
dc.identifier.orcid0000-0002-8146-1663
dc.identifier.orcid0000-0002-3369-8690
dc.identifier.orcid0000-0002-1280-0019
dc.identifier.orcid0000-0003-2252-0923
dc.identifier.orcid0000-0002-2487-2431
dc.identifier.orcid0000-0003-1879-1034
dc.identifier.pmid35243936
dc.identifier.scopus2-s2.0-85126051425
dc.identifier.scopusqualityQ3
dc.identifier.startpage193
dc.identifier.urihttps://doi.org/10.1080/1062936X.2022.2041723
dc.identifier.urihttps://hdl.handle.net/11129/14169
dc.identifier.volume33
dc.identifier.wosWOS:000764939000001
dc.identifier.wosqualityQ2
dc.indekslendigikaynakWeb of Science
dc.indekslendigikaynakPubMed
dc.indekslendigikaynakScopus
dc.language.isoen
dc.publisherTaylor & Francis Ltd
dc.relation.ispartofSar and Qsar in Environmental Research
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı
dc.rightsinfo:eu-repo/semantics/closedAccess
dc.snmzKA_WoS_20260204
dc.subjectAlzheimer's disease
dc.subjectantioxidant activity
dc.subjectmolecular docking
dc.subjectthiazolylhydrazine
dc.subjectDFT-D3
dc.titleSynthesis and molecular modelling of thiadizole based hydrazone derivatives as acetylcholinesterase and butyrylcholinesterase inhibitory activities
dc.typeArticle

Files